Determinants of human B cell migration across brain endothelial cells

Journal of Immunology

Volumn 170, Issue 9, 2003, Pages 4497-4505

  Alter, Andrea ^a   Duddy, Martin ^a   Hebert, Sherry ^a   Biernacki, Katarzyna ^a   Prat, Alexandre ^a   Antel, Jack P ^a   Yong, Voon Wee ^b   Nuttall, Robert K ^c   Pennington, Caroline J ^c   Edwards, Dylan R ^c   Bar Or, Amit ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL INTERACTION; CELL ISOLATION; CELL KINETICS; CELL MIGRATION; CELL TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; INHIBITION KINETICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; T LYMPHOCYTE; TRANSPORT KINETICS;

EID: 0037407306     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.9.4497     Document Type: Article

References (64)

1. Antel, J. P., and T. Owens. 1999. Immune regulation and CNS autoimmune disease. J. Neuroimmunol. 100:181.
2. Adams, C. W., R. N. Poston, and S. J. Buk. 1989. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J. Nat. Sci. 92:291.
3. Prineas, J. W., and C. S. Raine. 1976. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology 26:29.
4. Prineas, J. W., and R. G. Wright. 1978. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38:409.
5. Archelos, J. J., M. K. Storch, and H. P. Hartung. 2000. The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47:694.
6. Prineas, J. W., and J. S. Graham. 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10:149.
7. Gay, D., and M. Esiri. 1991. Blood-brain barrier damage in acute multiple sclerosis plaques: an immunocytochemical study. Brain 114:557.
8. + T cell priming in vivo. J. Immunol. 162:5695.
9. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905.
10. Svensson, L., K. B. Abdul-Majid, J. Bauer, H. Lassmann, R. A. Harris, and R. Holmdahl. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32:1939.
11. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immun. 3:944.
12. Gay, F. W., T. J. Brye, G. W. A. Dick, and M. M. Esiri. 1997. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion. Brain 120:1461.
13. Lucchinetti, C. F., W. Bruck, M. Rodriguez, and H. Lassmann. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6:259.
14. Lucchinetti, C., W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:707.
15. Asakura, K., D. J. Miller, L. R. Pease, and M. Rodriguez. 1998. Targeting of IgMκ antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18:7700.
16. Torcia, M., L. Bracci-Laudiero, M. Lucibello, L. Nencioni, D. Labardi, A. Rubartelli, F. Cozzolino, L. Aloe, and E. Garaci. 1996. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85:345.
17. Mackay, I. R., and F. R. Rosen. 2000. T-cell function and migration. N. Engl. J. Med. 1020:299.
18. Brown, K. A. 2001. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int. Immunopharm. 1:2043.
19. Gonzalez-Amaro, R., and F. Sanchez-Madrid. 1999. Cell adhesion molecules: selectins and integrins. Crit. Rev. Immunol. 19:389.
20. Alon, R., S. Chen, R. Fuhlbrigge, K. D. Puri, and T. A. Springer. 1998. The kinetics and shear threshold of transient and rolling interactions of L-selectin with its ligand on leukocytes. Proc. Natl. Acad. Sci. USA 95:11631.
21. Bradley, L. M., M. E. Malo, S. Fong, S. L. Tonkonogy, and S. R. Watson. 1998. Blockade of both L-selectin and α4 integrins abrogates naive CD4 cell trafficking and responses in gut-associated lymphoid organs. Int. Immunol. 10:961.
22. Andoh, N., H. Ohtani, C. Kusakari. A. Onodera, O. Hotta, S. Tomioka, and H. Nagura. 1996. Expression of E- and P-selectins by vascular endothelial cells in human tonsils. Acta Otolaryngol. 523:52.
23. Barker, C. F., and R. E. Billingham. 1977. Immunologically privileged sites. Adv. Immunol. 25:1.
24. Pulido, R., M. J. Elices, M. R. Campanero, L. Osborn, S. Schiffer, A. Garcia-Pardo, R. Lobb. M. E. Hemler, and F. Sanchez-Madrid. 1991. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4: correlation with distinct α4 epitopes. J. Biol. Chem. 266:10241.
25. Marlin, S. D., and T. A. Springer. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813.
26. Karpus, W. J., and K. J. Kennedy. 1997. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62:681.
27. Karpus, W. J., N. W. Lukacs, B. L. MeRae, R. M. Steiter, S. L. Kunkel, and S. D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-K in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.
28. Miyagishi, R., S. Kikuchi, C. Takayama, Y. Inoue, and K. Tashiro. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17.
29. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine and chemotactic responsiveness of type 1 helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
30. Tanaka, Y. 2000. T cell integrin activation by chemokines in inflammation. Arch. Immunol. Ther. Exp. 48:443.
31. Hartung, H. P., and B. C. Kieseier. 2000. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J. Neuroimmunol. 107:140.
32. Yong, V. W., C. Power, P. Forsyth, and D. R. Edwards. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat. Neurosci. 2:502.
33. Kallmann, B. A., S. Wagner, V. Hummel, M. Buttmann, A. Bayas, J. C. Tonn, and P. Rieckmann. 2002. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 16:589.
34. Wong, D., R. Prameya, and K. Dorovini-Zis. 1999. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58:138.
35. Prat, A., K. Biernacki, S. Pouly, J. Nalbantoglu, R. Couture, and J. P. Antel. 2000. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropathol. Exp. Neurol. 59:896.
36. Prat, A., K. Biernacki, J. F. Lavoie, J. Poirier, P. Duquette, and J. P. Antel. 2002. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch. Neurol. 59:391.
37. Bar-Or, A., E. M. Oliveira, D. E. Anderson, J. I. Krieger, M. Duddy, K. C. O'Connor, and D. A. Hafler. 2001. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 167:5669.
38. Cannella, B., and C. S. Raine. 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:424.
39. Biernacki, K., A. Prat, M. Blain, and J. P. Antel. 2001. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J. Neuropathol. Exp. Neurol. 12:1127.
40. Baker, A. H., D. R. Edwards, and G. Murphy. 2002. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115:1.
41. Prat, A., K. Biernacki, B. Becher, and J. P. Antel. 2000. B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines. J. Neuropathol. Exp. Neurol. 59:129.
42. Koshy, P. J. T., C. J. Lundy, A. D. Rowan, S. Porter, D. R. Edwards, A. Hogan, I. M. Clark, and T. E. Cawston. 2002. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum. 46:961.
43. 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57.
44. Frade, J. M. R., M. Mellado, G. del Real, J. C. Gutierrez-Ramos, P. Lind, and C. Martinez-A. 1997. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J. Immunol. 159:5576.
45. Jinquan, T., B. Moller, M. Storgaard, N. Mukaida, J. Bonde, N. Grunnet, F. T. Black, C. G. Larsen, K. Matsushima, and K. Thestrup-Pedersen. 1997. Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. J. Immunol. 158:475.
46. Schratzberger, P., S. Dunzendorfer, N. Reinisch, C. M. Kahler, and C. J. Wiedermann. 1997. Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro. Immunol. Lett. 58:167.
47. Harling-Berg, C. J., J. T. Park, and P. M. Knopf. 1999. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol. 101:111.
48. Hickey, W. F. 1999. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11:125.
49. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118.
50. Knopf, P. M., C. J. Harling-Berg, H. F. Cserr, D. Basu, E. J. Sirulnick, S. C. Nolan. J. T. Park, K. Geoffrey, E. J. Thompson, and W. F. Hickey. 1998. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J. Immunol. 161:692.
51. Baranzini, S. E., C. Elfstrom, S. Y. Chang, C. Butonoi, R. Murray, R. Higuchi, and J. R. Oksenberg. 2000. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of gene expression. J. Immunol. 165:6576.
52. Lucchinetti, C., W. Bruck, and J. Noseworthy. 2001. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr. Opin. Neurol. 14:259.
53. Steinman, L., R. Martin, C. Bernard, P. Conlon, and J. R. Oksenberg. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:505.
54. Miller, D. W. 1999. Immunobiology of the blood-brain barrier. J. Neurovirol. 5:570.
55. Prat, A., K. Biernacki, K. Wosik, and J. P. Antel. 2001. Glial influence on the human blood-brain barrier. Glia 36:145.
56. Archelos, J. J., S. Jung, M. Maurer, M. Schmied. H. Lassmann, T. Tamatani, M. Miyasaka, K. V. Toyka. and H. P. Hartung. 1993. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol. 34:145.
57. Okada, T., V. N. Ngo, E. H. Ekland, R. Forster, M. Lipp, D. R. Littman, and J. G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196:65.
58. Reif, K., E. H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Forster, and J. G. Cyster. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94.
59. Nielsen, L. S., J. Frydenberg, M. Lind, M. Deleuran, K. Stengaard-Pedersen, and B. Deleuran. 1997. CD19-selected B lymphocytes synthesize, secrete and migrate in the presence of IL-8: TNF-α and IP-10 are also B lymphocyte migratory factors. Cytokine 9:747.
60. D'Apuzzo, M., A. Rolink, M. Loetscher, J. A. Hoxie, I. Clark-Lewis, F. Melchers, M. Baggiolini, and B. Moser. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1788.
61. Gunn, M. D., V. N. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799.
62. Campbell, J. J., E. P. Bowman, K. Murphy, K. R. Youngman. M. A. Siani, D. A. Thompson, L. Wu, A. Zlotnik, and E. C. Butcher. 1998. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J. Cell Biol. 141:1053.
63. Brinckerhoff, C. E., and L. M. Matrisian. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3:207.
64. Miller, D. H., O. A. Khan, W. A. Sheremata, L. D. Blumhardt, G. P. Rice, M. A. Libonati, A. J. Willmer-Hulme, C. M. Dalton, K. A. Miszkiel, and P. W. O'Connor. 2003. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348:15.